Cargando…

P633: UPDATED SAFETY AND EFFICACY RESULTS OF ZANUBRUTINIB IN PATIENTS WITH B-CELL MALIGNANCIES WHO ARE INTOLERANT OF IBRUTINIB AND/OR ACALABRUTINIB

Detalles Bibliográficos
Autores principales: Shadman, Mazyar, Y. Levy, Moshe, Porter, Ryan, M. Burke, John, L. Cultrera, Jennifer, Misleh, Jamal, Sharman, Jeff, F. Zafar, Syed, By, Kunthel, Cohen, Aileen, Crescenzo, Rocco, Idoine, Adam, W. Flinn, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429398/
http://dx.doi.org/10.1097/01.HS9.0000969436.70152.b3